Literature DB >> 22571226

Effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis.

G Emingil1, B Han, G Ozdemir, T Tervahartiala, C Vural, G Atilla, H Baylas, T Sorsa.   

Abstract

UNLABELLED: Emingil G, Han B, Özdemir G, Tervahartiala T, Vural C, Atilla G, Baylas H, Sorsa T. The effect of azithromycin, as an adjunct to nonsurgical periodontal treatment, on microbiological parameters and gingival crevicular fluid biomarkers in generalized aggressive periodontitis. J Periodont Res 2012; 47: 729-739.
© 2012 John Wiley & Sons A/S Background and Objective:  To study the effectiveness of azithromycin in combination with nonsurgical periodontal therapy on clinical and microbiological parameters, and on the MMP-8 and TIMP-1 levels in gingival crevicular fluid, over a 6-mo time-period in patients with generalized aggressive periodontitis. MATERIAL AND METHODS: Thirty-two patients with generalized aggressive periodontitis were included in this randomized, double-blind, placebo-controlled, parallel-arm study. They were randomly assigned to azithromycin or placebo groups (500 mg once daily for 3 d). Probing depth, clinical attachment levels, presence of bleeding on probing and plaque were recorded. Gingival crevicular fluid samples were obtained from one single-rooted tooth, while microbiological samples were obtained from two single-rooted teeth, all with a probing depth of ≥ 6 mm. Microbiological parameters were analyzed by quantitative real-time PCR for Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Tannerella forsythia, Fusobacterium nucleatum, Prevotella intermedia and total bacteria. Gingival crevicular fluid biomarkers were determined by immunofluorometric assay and ELISA. RESULTS: All clinical parameters improved, and microbiological parameters and gingival crevicular fluid MMP-8 levels significantly decreased, over the 6-mo period (p < 0.05); both groups demonstrated similar improvements. The azithromycin group presented a higher percentage of deep pockets resolved (probing depth reduction of ≥ 3 mm from baseline) compared with the placebo group at 1 mo (p < 0.05). CONCLUSION: Adjunctive azithromycin therapy provides no additional benefit over nonsurgical periodontal treatment on clinical parameters, microbiological parameters and gingival crevicular fluid biochemical markers investigated in patients with generalized aggressive periodontitis. © 2012 John Wiley & Sons A/S.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22571226     DOI： 10.1111/j.1600-0765.2012.01488.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN： 0022-3484            Impact factor:   4.419


  12 in total

Review 1.  Clinical Efficacy of Azithromycin as an Adjunctive Therapy to Non-Surgical Periodontal Treatment of Periodontitis: A Systematic Review and Meta-Analysis.

Authors:  Antonio Renatus; Jörg Herrmann; Antje Schönfelder; Fabian Schwarzenberger; Holger Jentsch
Journal:  J Clin Diagn Res       Date:  2016-07-01

Review 2.  Non-surgical periodontal therapy supplemented with systemically administered azithromycin: a systematic review of RCTs.

Authors:  Sabrina L Buset; Nicola U Zitzmann; Roland Weiger; Clemens Walter
Journal:  Clin Oral Investig       Date:  2015-06-12       Impact factor: 3.573

Review 3.  Antibacterial and immunomodulatory properties of azithromycin treatment implications for periodontitis.

Authors:  P M Bartold; A H du Bois; S Gannon; D R Haynes; R S Hirsch
Journal:  Inflammopharmacology       Date:  2013-02-28       Impact factor: 4.473

4.  Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole.

Authors:  Holger F R Jentsch; Andreas Buchmann; Abel Friedrich; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2015-12-19       Impact factor: 3.573

5.  Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis.

Authors:  Patricia Furtado Gonçalves; Hong Huang; Suzanna McAninley; Barnett Alfant; Peter Harrison; Ikramuddin Aukhil; Clay Walker; Luciana Macchion Shaddox
Journal:  J Periodontol       Date:  2013-03-28       Impact factor: 6.993

Review 6.  Amoxicillin/Metronidazole Dose Impact as an Adjunctive Therapy for Stage II - III Grade C Periodontitis (Aggressive Periodontitis) at 3- And 6-Month Follow-Ups: a Systematic Review and Meta-Analysis.

Authors:  Malihe Karrabi; Zahra Baghani
Journal:  J Oral Maxillofac Res       Date:  2022-03-31

7.  Impact of metronidazole and amoxicillin combination on matrix metalloproteinases-1 and tissue inhibitors of matrix metalloproteinases balance in generalized aggressive periodontitis.

Authors:  Emine Cifcibasi; Alpdogan Kantarci; Selim Badur; Halim Issever; Serdar Cintan
Journal:  Eur J Dent       Date:  2015 Jan-Mar

Review 8.  Identification of Gingival Crevicular Fluid Sampling, Analytical Methods, and Oral Biomarkers for the Diagnosis and Monitoring of Periodontal Diseases: A Systematic Review.

Authors:  Zeyad Nazar Majeed; Koshy Philip; A M Alabsi; Saravanan Pushparajan; Dasan Swaminathan
Journal:  Dis Markers       Date:  2016-12-15       Impact factor: 3.434

9.  Adjunctive systemic antimicrobials for the non-surgical treatment of periodontitis.

Authors:  Shivi Khattri; Sumanth Kumbargere Nagraj; Ankita Arora; Prashanti Eachempati; Chandan Kumar Kusum; Kishore G Bhat; Trevor M Johnson; Giovanni Lodi
Journal:  Cochrane Database Syst Rev       Date:  2020-11-16

10.  Azithromycin buccal patch in treatment of chronic periodontitis.

Authors:  Sajith Abdul Latif; K L Vandana; J Thimmashetty; Priyanka Jairaj Dalvi
Journal:  Indian J Pharmacol       Date:  2016 Mar-Apr       Impact factor: 1.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.